Past Clinical Trials | NYU Langone Health

Skip to Main Content
Vaccine Clinical Trials Past Clinical Trials

Past Clinical Trials

Learn more about past clinical trials led by NYU Langone’s Vaccine Center.

Phase 1/2 Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates Against COVID-19 in Healthy Adults

Study of Recombinant Protein Vaccines with Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older

Evaluating the Safety, Tolerability, Efficacy, and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants at Least 12 Years of Age

Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-CoV-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

Randomized Phase 2 Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection (CONSORTIUM)

A Multicenter, Adaptive, Randomized, Blinded, Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT4)

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies for Prevention of SARS-CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual with a Positive SARS-CoV-2 RT-PCR Assay

A Randomized Placebo-Controlled, Double-Blind Sponsor Unblinded Single Ascending Dose Phase 1 First in Human Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Intravenous LY3819253 in Participants Hospitalized for COVID-19

A Study of SARS-CoV-2 Infection and Potential Transmission in Individuals Immunized with Moderna COVID-19 Vaccine